Noel Harvey is Vice President, Research and Development at BD Technologies in Research Triangle Park, NC. As a component of BD’s Office of Science, Medicine, and Technology, BD Technologies is tasked with identifying and developing innovative new technology that can be applied to new products that meet significant unmet medical needs across the globe.
Dr. Harvey has initiated and led collaborative research and development programs funded by Pfizer, Eli Lilly, Amgen, the National Institutes of Health, the Bill and Melinda Gates Foundation, and the US Department of Defense. All of these collaborations were centered on use of device technology to improve healthcare practices in the developed and developing worlds. Noel has also represented BD in Washington DC on matters regarding biodefense, pandemic preparedness, and vaccine policy and is a frequent review panelist for the National Institutes of Health and the National Science Foundation.
Dr. Harvey holds a PhD in Physical Chemistry from Duke University. A winner of the Howe Award for Technological Innovation, the Haas Award for Scientific Excellence, and the Hauser Award for Physical Chemistry, he holds over 35 patents and has authored more than 50 peer reviewed scientific publications. He has worked at BD for 20 years.